Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by MEDEX.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
MEDEX
ClinicalTrials.gov Identifier:
NCT00199979
First received: September 12, 2005
Last updated: December 15, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2008
  Estimated Primary Completion Date: No date given